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Abstract There is an immense need for tissue engineered
blood vessels. However, current tissue engineering approaches
still lack the ability to build native blood vessel-like perfusable
structures with multi-layered vascular walls. This paper dem-
onstrated a new method to fabricate tri-layer biomimetic blood
vessel-like structures on a microfluidic platform using
photocrosslinkable gelatin hydrogel. The presented method en-
ables fabrication of physiological blood vessel-like structures
with mono-, bi- or tri-layer vascular walls. The diameter of the
vessels, the total thickness of the vessel wall and the thickness
of each individual layer of the wall were independently con-
trolled. The developed fabrication process is a simple and rapid
method, allowing the physical fabrication of the vascular struc-
ture in minutes, and the formation of a vascular endothelial cell
layer inside the vessels in 3–5 days. The fabricated vascular
constructs can potentially be used in numerous applications
including drug screening, development of in vitro models for
cardiovascular diseases and/or cancer metastasis, and study of
vascular biology and mechanobiology.
Keywords Tissue engineering .Microfluidics . Blood
vessel . Hydrogel . PDMS .Microfabrication
1 Introduction
Cardiovascular diseases are amongst the major causes of fa-
talities worldwide (Hasan et al. 2015;Tu et al. 1997; Ratcliffe
2000). Each year 1.4 million patients in US alone need arterial
prosthesis (Browning et al. 2012). This has created a tremen-
dous need for tissue engineered artificial blood vessels that
could be used not only for replacement or bypass of damaged
arteries but also for the development of in vitro models of
vascular diseases, drug discovery and organ-on-a-chip plat-
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forms (Hasan et al. 2014a, b). Besides, for widespread clinical
application of tissue engineering, vascularization of three di-
mensional (3D) tissue constructs remains a major problem
(Barthes et al. 2014; Du et al. 2008; Hasan et al. 2014d; Miller
et al. 2012; Novosel et al. 2011; Sudo et al. 2009). The devel-
opment of proper vascularization methods will enable tissue
engineering of thick, complex 3D tissue constructs, particular-
ly those comprising large vital organs such as liver, kidney and
heart (Kaully et al. 2009). Similarly, the ability to form artifi-
cial blood vessels on-chip will pave the way for development
of in vitro models of vascular diseases, which could revolu-
tionize the generation of new therapeutics for atherosclerosis,
hypertension, heart attack, stroke and many other diseases
(Hasan et al. 2014a, b). Extensive research over the past two
decades has been aimed at the development of viable tissue
engineered blood vessels. However, achieving the goal of a
viable tissue engineered blood vessel remains elusive. In par-
ticular, the current approaches of tissue engineering still lack
the ability to form perfusable blood vessels with native-like
tri-layered architecture.
Researchers have employed numerous methods to form
blood vessel-like structures in vitro which can be broadly
classified into two types, namely (i) angiogenesis based ap-
proaches forming blood vessel capillaries and (ii)
prevascularization based approaches for generating larger ves-
sels. In the angiogenesis based approaches, the directional
migration and self-organization of specific cell types under
controlled microenvironments are used for promoting the for-
mation of microvascular-like structures (Chung et al. 2009;
Sudo et al. 2009; Saik et al. 2012; Leslie-Barbick et al.
2009, 2011a, b; Chen et al. 2007; Cao et al. 2009; Yuen
et al. 2010; Yeon et al. 2012; Mendes et al. 2012; Chen
et al.,2012). For instance, a sprouting assay of endothelial cells
(ECs) on microbeads was introduced where vascular tube-like
structures were successfully formed (Shamloo and Heilshorn
2010; Shamloo et al. 2012; Nakatsu et al. 2003). However,
these vascular structures were closed. Kamm and colleagues
used co-culture of ECs with fibroblast cells in a microfluidic-
based approach to guide a directional migration of EC into a
hydrogel, resulting in formation of endothelial sprouts and
hence blood vessel capillary-like structures (Chung et al.
2009; Sudo et al. 2009). West (Saik et al. 2012; Leslie-
Barbick et al. 2009, 2011a, b) and Mooney (Chen et al.
2007; Cao et al. 2009; Yuen et al. 2010) used immobilization
and delivery of various angiogenic growth factors in matrix
materials for promoting formation of vascular structures. Co-
culture of various cells such as ECs with mesenchymal stem
cells (MSCs) in type I collagen or Matrigel (Darland and
D’Amore 2001) and endothelial colony forming cells
(ECFCs) with MSCs in gelatin methacryloyl (GelMA)
(Chen et al. 2012) were also investigated. However, limita-
tions of these approaches include the fact that the structures
formed using these approaches are not readily perfusable.
In the alternative prevascularization based approaches,
vascular structures are formed by encapsulating or surface
seeding vascular cells in a preformed vascular network or
tube within a 3D hydrogel construct. A major advantage
of this approach is that it allows immediate perfusion of
the constructs, helping the growth and proliferation of the
cells. Moreover, the delivery of oxygen and nutrients, and
the removal of metabolic wastes can be performed con-
tinuously (Price et al. 2010; Chrobak et al. 2006; Zheng
et al. 2012; Sadr et al. 2011; Miller et al. 2012; Yoshida
et al. 2012; Khademhosseini et al. 2004, 2005). However,
vascular constructs reported so far based on this approach
consisted of either a single monolayer of ECs (Price et al.
2010; Chrobak et al. 2006), or a bilayered construct of
ECs with smooth muscle cells (SMCs) in one example
(Yoshida et al. 2012). The native arterial and venous wall
on the other hand are composed of three layers: (i) tunica
intima, a continuous monolayer of ECs, (ii) tunica media,
dense populations of concentrically organized SMCs, and
(iii) adventitia, a collagenous extracellular matrix (ECM)
that mainly contains fibroblast cells and perivascular
nerve cells. Fully recapitulating the well-organized tri-lay-
er wall structure is important for proper functioning of
artificial tissue engineered blood vessels. A tri-layer struc-
ture could also provide better understanding of the cell-
cell signaling and interactions between the ECs, SMCs,
and fibroblast cells during the initiation, progression and
curing of various vascular diseases.
Here we report the development of a tri-layered
perfusable vascular-like structure on a microfluidic plat-
form using a simple method based on a concentric layer-
by-layer organization of vascular cells, namely, fibroblast
cells, SMCs and ECs in a photocrosslinkable 3D hydro-
gel. We choose GelMA hydrogels because of their tun-
able mechanical properties and the fast and easy
crosslinking with precise control over the time and den-
sity of photocrosslinking. The tri-layer structures of 0.6
and 1.2 mm outer diameters can be formed with lumen
diameters in the range of 120–400 μm and the lumen to
wall thickness ratio of 0.22–1.0. The mechanical proper-
ties of the walls of the vascular-like structures can also be
varied by varying the GelMA concentration in the range
4–16 %. The higher concentration GelMA (12 % and
higher) resulted in better vessel structures with smoother
luminal surfaces compared to lower concentration
GelMA. A confluent monolayer of EC in the luminal
surface was formed in 3–5 days and barrier function of
the endothelial monolayer was analyzed in detail using
the permeation of fluorescently labeled probes. The ves-
sels demonstrated here could be useful in numerous ap-
plications including development of in vitro human tissue
based platforms for drug discovery, disease models and
mechano-biological studies.
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2 Experimental
2.1 Materials and reagents
Polydimethylsiloxane (PDMS; Sylgard 184) was pur-
chased from Dow Corning, Midland, MI). Petri dishes,
cover slips, and glass slides were purchased from Fisher
Scientific (Philadelphia, USA). Type A gelatin (porcine
skin), 3-(trimethoxysilyl)propyl methacrylate (TMSPMA),
and methacrylic anhydride (MA), were obtained from
Sigma-Aldrich (Wisconsin, USA). Irgacure 2959
photoinitiator (2-hydroxy-1-(4-(hydroxyethoxy), phenyl)-
2-methyl-1-propanone purchased from CIBA Chemicals)
was initiated by an ultraviolet (UV) light source
(Omnicure S2000) manufactured by EXFO Photonic So-
lutions Inc. (Canada). 120 μm, 200 μm and 300 μm–di-
ameter; 30 and 40 mm long stainless steel acupuncture
needles were purchased from Seirin Corporation, Japan,
while 400 μm, 500 μm and 800 μm hypodermic stainless
steel needles (27G, and 21G respectively) were purchased
from BD precisionGlide®, Franklin Lakes, NJ. Endothe-
lial basal medium-2 (EBM-2, CC-3156, Lonza) and endo-
thelial growth bulletkit (EGM-2; CC-3162, Lonza) sup-
plements were purchased from Lonza (Switzerland). All
other chemicals and reagents were purchased from Sigma
Aldrich (USA) unless otherwise indicated.
2.2 GelMA synthesis
Synthesis of GelMA was performed as described previ-
ously (Van Den Bulcke et al. 2000; Nichol et al. 2010;
Benton et al. 2009; Paul et al. 2014). In brief, type-A
gelatin obtained from porcine skin was dissolved in
Dulbecco’s phosphate buffered saline (DPBS) (Gibco,
USA), at 10 % (w/v) concentration by heating at 60 °C
on a hot plate while continuously stirring for 1 h using a
magnetic stirrer. Then, 8 ml of methacrylic anhydride was
added drop-wise per 100 ml of gelatin solution at a rate of
0.5 ml/min, keeping the temperature at 50 °C and contin-
uously stirring the solution for 3 h. The solution was then
diluted to 1/5th of the initial concentration by adding pre-
warmed (40 °C) DPBS, thereby stopping any further re-
action. The diluted mixture was dialyzed using a 12–
14 kDA dialysis membrane for 1 week against distilled
water at 40 °C, followed by filtration through a 0.2 μm
filter, overnight storage at−80 °C, and finally, lyophilizing
for 1 week. This white porous foam of GelMA was stored
at−80 °C until further use.
2.3 Cell culture
The cells used in this study were of three different types,
namely, (i) human umbilical vein endothelial cells (HUVECs;
a generous gift from Dr. J. Folkman, Children’s Hospital,
Boston) with constitutive green fluorescent protein (GFP) ex-
pression, (ii) rat aortic SMCs, and (iii) 3T3 fibroblast cells.
The cell culture media for HUVECs was prepared using en-
dothelial growth bulletkit (EGM-2; Lonza) supplement in en-
dothelial basal medium, (EBM-2; Lonza), with 10 % fetal
bovine serum (FBS) and 1 % penicillin plus streptomycin.
The SMC and 3T3 media consisted of Dulbecco’s Modified
Eagle Medium, DMEM, supplemented with 10 % FBS and
1 % penicillin plus streptomycin. The cells were cultured at
37 °C, in standard cell culture incubator (5 % CO2) for up to
70–80 % confluence before passaging to new flasks or using
them in an experiment.
2.4 Fabrication of PDMS microfluidic device
The microfluidic device was fabricated using small glass
capillary tubes (1.2 and 0.6 mm internal diameter, 15 mm
long) embedded in a PDMS device to provide it with
mechanical support and stability. The device consisted of
three layers: (i) the top layer, a rectangular PDMS slab
with an inlet and outlet tubing connected to it, (ii) the
middle layer containing two punched holes for inlet and
outlet reservoirs and a channel to house the vessel to be
fabricated, and (iii) the bottom layer, a rectangular piece
of glass slide. At first the inner surface of the glass
capillaries/tubes were coated with TMSPMA coating
(Nichol et al. 2010). The glass capillaries of desired size
were immobilized in a petri dish using PDMS glue. The
capillaries were then casted in PDMS rubber by pouring
liquid PDMS (10:1 ratio of silicon base Sylgard to curing
agent) in the petri dish. The liquid PDMS was cured at
80 °C in an oven for 2 h upon which it became solidified.
The flat PDMS, was cut into rectangular parts (15×
25 mm), each one with an embedded glass capillary in-
side. The glass capillary was removed leaving a tubular
channel. Two circular holes were punched into the PDMS
near the two ends of the capillary channel to make inlet/
outlet media reservoirs, and a second piece of glass cap-
illary coated with TMSPMA on their inner surface was
inserted inside the channel to replace the first one. This
PDMS part was then bonded to the bottom layer of the
device using oxygen plasma bonder. The entire device
was affixed in a petri dish using PDMS as glue. In an
alternate approach, the middle layer of the PDMS device
was fabricated by casting liquid PDMS on a silicon wafer
mold prepared using microfabrication techniques, and the
glass capillary was inserted into the PDMS layer after-
wards. The top part of the PDMS device was prepared
along with its inlet and outlet tubing to close the PDMS
device from top side after the blood vessel fabrication was
done. At this stage the microfluidic device was ready for
use as shown schematically in Fig. 1a (i).
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Fig. 1 Schematic illustration of the step-by-step fabrication process of
the tri-layer blood vessel-like structure in a microfluidic device, a (i) the
middle layer of the three-layer PDMS device was fabricated by casting
liquid PDMS on a silicon wafer mold prepared using microfabrication
technique or as described in section 2.4. A glass capillary tubewas affixed
in the channel inside the middle part of the device which was plasma
bonded to the bottom layer, a glass slide, (ii) two concentric needles
were inserted in the device from opposite ends. The outer space was
filled with fibroblast cell-laden GelMA, (iii) the gel outer layer
encapsulated with fibroblast cells was photocrosslinked, (iv) The outer
needle was pulled out leaving a concentric annular gap between inner
needle and the outer gel layer. GelMA prepolymer solution laden with
SMCs was pipetted into the concentric annular space. (v) The inner gel
layer, GelMA laden with SMCs, was photocrosslinked. (vi) The inner
needle was carefully pulled out leaving a bilayer cellular structure in the
microfluidic device. Needle entrances were sealed, and HUVECs were
seeded inside lumen resulting in a tri-layer vascular-like structure. b
Perfusion of cell culture media through the fabricated structure in the
microfluidic device was established, c the tri-layer vascular structure
fabricated through the process
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2.5 Fabrication of blood vessel-like structures
with multilayered vessel walls using concentric needles
in GelMA hydrogel
The method that we employed for fabrication of blood vessel-
like structures uses a pair of concentric stainless steel needles.
The outer needle is a hypodermic needle with its inner diameter
being larger than the outer diameter of the inner needle. For
fabrication of vessels with different wall thicknesses, different
sizes of needle pairs were used, for example 21G, BD (outer
diameter: 800 μm, inner diameter: 500 μm) and 27G, BD (out-
er diameter: 400 μm, inner diameter: 196 μm), or 25G, BD
(outer diameter: 500 μm, inner diameter: 400 μm) and 200S
Serine needle (outer diameter: 200 μm) were used respectively.
A schematic representation of the step by step process for
fabrication of multilayered vascular structure is presented in
Fig. 1a. At first two sterile stainless steel needles were inserted
concentrically in the microfluidic device from the two oppo-
site ends, Fig. 1 (ii). Fibroblasts and SMCs were trypsinized
from a cell culture flask and mixed in separate GelMA pre-
polymer solutions at a density of 2×106 cells/ml. Different
pre-polymer concentrations of GelMA solution were used
ranging from 4 to 16 %. The fibroblast cell laden GelMA
pre-polymer solution was pipetted into the annular gap be-
tween the larger needle and the glass capillary inside the
microfluidic device, Fig. 1 (ii), and was crosslinked with light
(360–480 nm) at power 5.9 mw/cm2, from a vertical distance
of 81 mm by exposing the device to light for 30 s from both
top and bottom side, Fig. 1 (iii). The outer needle was pulled
out gently leaving a concentric annular gap between the newly
formed hydrogel layer and the inner needle. The second pre-
polymer GelMA solution, laden with SMC, was pipetted into
the concentric annular gap, Fig. 1 (iv), followed by a second-
step photocrosslinking, Fig. 1 (v). Finally the inner needle was
also gently pulled out creating a bilayer tubular structure with
a lumen inside. The needle entrances on both ends of the
microfluidic device were sealed using partially cured PDMS.
The lumen of the bilayer structure was washed out by flowing
PBS through it. In order to pre-condition the bi-layer GelMA
construct for seeding of HUVECs, cell culture media was
passed through the lumen of the vessel for few hours.
HUVECs were trypsinized, centrifuged and suspended in
HUVEC media at a cell density of 20×106 cells/ml. The
HUVEC suspension was injected into the lumen of the vessel,
observed under the microscope for proper cell loading, and
incubated inside the tissue culture incubator for 4 h for cell
adhesion to the luminal surface. After 4 h, the non-adherent
cells were washed out. The top layer PDMS slab with an inlet
and an outlet tubing was connected from the top side of the
microfluidic device thereby closing the device. A continuous
flow of HUVECmedia was set up through the device at a rate
of 30–50 μL/h using a syringe pump. In 3–5 days a fully
confluent monolayer of HUVECs was formed on the inner
surface of the lumen, resulting in a tri-layer blood vessel-like
structure with fibroblast cells in the outer layer, SMCs in the
middle layer and HUVEC mono layer on the luminal surface.
2.6 Live-dead staining for cell viability in vessel wall
The viability of 3T3 fibroblast cells in the walls of the vessel
was investigated using an Invitrogen live-dead assay kit fol-
lowing supplier protocols. To do so, the media from the well
plates was removed and the vessels were washed by PBS. A
solution of 2μL/ml ethidium homodimer (EthD-1) and 0.5μL/
ml calcein AM in PBSwas added to the well plates, which was
then incubated for 20min inside the incubator at 37 °C. Finally,
the vessels were washed by PBS and the live (green) and dead
(red) cells were imaged using an inverted fluorescent micro-
scope (Nikon TE 2000-U, Nikon Instrument Inc., USA). The
obtained live-dead staining images were analyzed using the
image analysis software ImageJ, whereby the viability of cells
was calculated from the ratio of live to total cells.
2.7 Phalloidin-DAPI staining for cytoskeletal actin fibers
and nuclei of cells
The cells in the vascular structure inside the microfluidic de-
vice were fixed on the fifth day after a continuous monolayer
of HUVECs was formed on the luminal surface. The cells
were fixed in 4 % paraformaldehyde for 30 min, and
permealized using 0.1 % Triton X for 20 min. 1 % bovine
serum albumin (BSA) in PBS was used to block non-
specific sites for 1 h. Finally, the cytoskeletal actin fibers of
the HUVEC monolayer were stained using Alexa Fluor 488
(green) and the nucleus of the cells were stained with DAPI
(blue).
2.8 Imaging cross-sections of the engineered vessels
For fluorescent images, the vascular-like structure was fabri-
cated following the same protocol as described in section 2.5
but using fluorescent red, blue and green microbeads instead of
the fibroblasts, SMCs and HUVECs. The constructs were then
embedded in polyethylene glycol (PEG) hydrogel and sliced
into thin layers. For embedding into PEG, 20 % PEG (Mw=
1000) was dissolved in 0.5 % Irgacure photoinitiator solution
prepared using PBS. The pre-polymer solution was pipetted
into the lumen of the engineered vascular construct, and was
exposed to UV light for 1 min at 5.9 mw/cm2 from both top
and bottom sides thereby filling the PEG hydrogel inside the
lumen. Filling the lumen of the vascular constructs with PEG
before sectioning helped in maintaining the circular shape of
the cross-sections. The constructs were taken out from the
glass capillaries and hence the microfluidic devices by careful-
ly pushing them from one end using a glass rod<1 mm diam-
eter. For ease of removal of the vessel from the glass capillary
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Poly(N-isopropylacrylamide) (polyNipam) coating was ap-
plied on them prior to insertion into the microfluidic device.
The constructs were then sliced into very thin sections and
imaged using fluorescent microscope.
2.9 Measurement of mechanical properties
Since the high aspect ratio (long narrow) vessels of hydrogel,
as prepared in this study, are susceptible to buckling during
axial compressive loading, for stability of the samples during
mechanical testing, the cross-section of the vascular constructs
was scaled up by five times its original cross-section. To do so,
monolayered vascular constructs were formed using 2×106
cells/ml of SMC encapsulated in GelMA with a 6 mm outer
diameter (glass capillary) and 1 mm lumen diameter by using
an 18G hypodermic needle in a PDMS device. The vascular
constructs after removal from the PDMS device were washed
in PBS, cut to 3 mm length, submerged in cell culture media,
and stored in the incubator at 37 °C. The constructs were blot-
ted with a KimWipe lightly before placing on the platen for
mechanical testing. The uniaxial compressive mechanical tests
were performed at a rate of 1 mm/min using an Instron 5943
mechanical tester.
2.10 Evaluation of the barrier function of the engineered
vessels
To evaluate the barrier function of the HUVEC monolayer in
the lumen of the vascular constructs, a 100 μg/ml solution of
Alexa-Fluor-488 labeled dextran (10 kDA) in PBSwas passed
through the lumen of the constructs. Fluorescent images were
captured every 10 min for up to 60 min at the same location of
the device. The fluorescent intensities were plotted using the
plot profile function of ImageJ software along a straight line
across the tube near half way from both ends. The data were
obtained in triplicates with at least three scanning lines for
each construct and repeating the measurements in three con-
structs for each set of results. The obtained fluorescent inten-
sities were normalized by dividing with the maximum inten-
sity value in the vessel which was the intensity along the
center axis line. Finally, the barrier to the diffusion was calcu-
lated from the temporal change in relative intensity at a dis-
tance 300 μm from the center line at different time points.
3 Results and discussions
In this paper we present the development of a multi-layered
blood vessel-like structures on a microfluidic platform. These
fabricated blood vessel-like structures consisted of up to a tri-
layered architecture with high reproducibly and consistency.
Furthermore, the mechanical properties of each layer of the
wall, the number of cell lines to be incorporated, the cell types
and the cell density in individual layers could each be inde-
pendently tuned.
3.1 Fabrication of Tri-layered vascular structure using
GelMA hydrogel in microfluidic device
The detailed step-by-step process for fabrication of the tri-
layer vascular structure is shown in Fig. 1a. The perfusion of
cell culture media through fabricated vascular structure using
a syringe pump is shown in Fig. 1b while a schematic drawing
of the three arterial/vein layers is shown in Fig. 1c. The readily
fabricated hollow channel in the vessel allowed perfusion of
media, as shown using a fluorescent dye in Figs. 2a (i) and (ii).
In addition, cells can be encapsulated in GelMA hydrogel to
form monolayered, Figs. 2b (i), (ii), and multilayered vascular
walls Figs. 2c (i), (ii) and (iii)). The construction of multilay-
ered wall structure is demonstrated using fluorescent
microbeads of red, blue and green colors, Fig. 2c. Fabrication
of vascular structures with different thicknesses and lumen
diameters can be achieved by using combinations of different
stainless steel needle pairs as shown in Table 1. For example, a
pair of 27G BD needle (outer diameter: 400 μm, ID: 196 μm)
with a 120 μm Serine needle inside the 1.2 mm glass capillary
resulted in a vascular-like structure with an outer diameter:
1.2 mm, thickness of adventitia layer: 400 μm, thickness of
tunica media layer: 140 μm and a lumen diameter of 120 μm,
as shown in Fig. 2(c) (ii). Similarly, a pair of 21G and 27G BD
needles resulted in a vessel with the outer diameter, adventitia
thickness, media thickness and lumen diameter of 1.2 mm,
200 μm, 200 μm and 400 μm respectively.
In native cardiovascular systems, the outer and lumen di-
ameter of the vessels, the thickness of different wall layers and
the mechanical properties of the tissue matrix vary in different
layers. For example, the vascular walls for vessels close to the
heart are thicker compared to those of vessels far away. Sim-
ilarly, the relative thickness of tunica media and adventitia
vary between the elastic and muscular arteries. Thus, the abil-
ity to independently control the thickness of different layers
along with the luminal and outer diameter, as described in this
study, can be useful in the development of biomimetic blood
vessels-like structures of different types. In addition, the com-
position and mechanical properties of different layers of phys-
iological blood vessels also differ among themselves. While
the ECM of tunica media is highly elastic, comprised of col-
lagen type I and III, elastin and several proteoglycans, the
ECM in adventitia are more collagen rich. Our method also
allows variation of composition and mechanical properties of
individual layers of the tri-layer constructs. By varying the
concentration of GelMA, for example, or possibly by incor-
porating different bio-active compounds (peptides, proteins
etc.) in the GelMA prepolymer solution, the mechanical prop-
erties and biological responses of different layers can be inde-
pendently controlled.
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3.2 Effect of GelMA concentration on tube formation
The method used in this study for fabrication of vascular-like
structures is based on molding of photocrosslinkable GelMA
hydrogel around stainless steel needles and smoothly remov-
ing the needles after the gel layers are formed. In order to
facilitate the smooth retraction of needles from the gel, the
needles were pre-coated with BSA by soaking them in a
1 % BSA solution for 40 min. However, it was noticed that
the concentration of GelMA played a more prominent role in
determining how smoothly the needles could be removed
from the gel. A set of representative images of tubes formed
using different concentrations (e.g., 4, 8, and 12 %) of
GelMA is shown in supplementary Figure, Fig. S1. It is
evident that the tubes with mechanically weaker hydrogels
(4 % GelMA) got severely damaged with clearly visible
cracks, tears, and wavy undulations during the retrieval
of needle. For gels of higher concentrations (12 % and
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Fig. 2 Illustration of the single and multilayer vascular-like structures, a
a tubular Channel fabricated in bare GelMA: (i) phase contrast images of
a 200 μm channel in bare GelMA, (ii) fluorescent image after flowing
FITC through a 200 μm channel in GelMA; b a single layer vascular-like
construct; (i) fluorescent image of top view of the vascular-like structure
with green fluorescent beads encapsulated in the wall, (ii) cross-sectional
side view of the structure showing the lumen and the wall of the construct;
c a multilayer vascular-like structure: (i) top view bright field image of the
bilayer structure, (ii) top view of the bilayer structure with fluorescent
beads of different colors encapsulated in different layers, (iii) cross-
sectional side view of the structure showing the lumen and the two
layers of the wall. Scale bars=200 μm
Table 1 Specifications of the vascular-like constructs that can be fabricated using combinations of needle pairs of different sizes
Specifications of glass capillary and needles Specifications of fabricated vascular constructs
Capillary
diameter (mm)
Outer needle Inner needle Adventitia
(μm)
Media (μm) Lumen (μm) Vessel diameter
(mm)
Total wall
thickness
Gage OD (μm) ID (μm) Gage OD (μm) ID (μm)
1 1.2 27G 400 196 120S 120 N/A 400 140 120 1.2 540
2 1.2 25G 508 406 200S 200 N/A 346 164 200 1.2 500
3 1.2 21G 800 241 27G 400 196 200 200 400 1.2 200
4 0.6 27G 400 196 120S 120 N/A 100 102 120 0.6 240
5 1.2 25G 508 406 200S 200 N/A 42 154 200 0.6 200
6 6 18G 1000 Monolayer vessel for mechanical test 2500 - 1000 6.0 2500
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higher) the luminal surface of the tubes after retrieval of
needles were smooth and relatively defect-free. The higher
concentration GelMA was therefore easier for fabrication
of vessels from structural and mechanical perspectives.
However, too high of a concentration is not helpful for
good cell viability. Therefore obtaining optimum concen-
tration is important.
While previous studies on collagen and fibrin hydrogel
reported contraction of the vessel after EC seeding followed
by expansion due to the forces from cells (Wong et al. 2010),
the GelMA vessels, particularly those from higher GelMA
concentrations, did not show any significant change in diam-
eter after cell seeding. This could possibly be attributed to the
higher stiffness i.e., the better mechanical properties of
GelMA hydrogel compared to collagen and fibrin hydrogels.
For low concentration GelMA, particularly the 4 % gels, the
vessels did appear to contract after seeding of HUVECs, how-
ever, those concentrations were not used in subsequent exper-
iments. Similarly, we did not observe any invasion of
HUVECs from the lumen surface into the gel matrix.
3.3 Viability of cells in the walls of fabricated vessels
To understand the effect of GelMA concentration on the via-
bility of encapsulated cells in the wall and to further tune the
GelMA concentration for fabrication of vessels, the viability
of fibroblast cells fibroblast cells in the wall was investigated
for different GelMA concentrations (4, 8, 12 and 16%). In this
attempt, the vascular structure after fabrication were taken out
of the microfluidic device and cultured in multiwell plates
inside an incubator. The live-dead images and the viability
fibroblast cells in the walls of the fabricated vessels performed
at different time points are shown in Figs. 3a–c. The 4–12 %
concentration samples showed higher cell viability compared
to 16 % concentration samples.
3.4 Effect of lumen diameter on seeding of HUVECs
While most tubes formed in this study had an initial lumen
diameter of 200 μm, we also formed the endothelial monolay-
er in tubes of four other sizes i.e., 120, 180, 300 and 400 μm.
These tubes were made using Seirin needles 120S, 180S,
300S, and BD needle 27G respectively. Some tubes of
120 μm lumen-diameter occasionally became clogged during
cell seeding and seized to flow when a high cell density were
used in seeding. We used a lower cell density, 15×106 cells/
ml, for effective seeding of these small diameter tubes. In
larger diameter tubes, i.e., 300 and 400 μm, higher (up to
30×106 cells/ml) cell densities were used.
The seeding was relatively difficult for larger diameter ves-
sels as most cells entering from one end of the tube would pass
through the tube and exit from the other end leaving very
small number of cells retained inside the tube. It is known
from physics of fluid flow that the flow resistance is inversely
proportional to the square of the tube diameter.
3.5 Cell adhesion and HUVECs monolayer formation
Formation of a continuous monolayer of ECs in the luminal
surface is essential for fabrication of a functional blood vessel
mimic. Hence, the adhesion and spreading of ECs on the lumi-
nal surface must be ensured. We optimized the adhesion of
HUVECs on 4, 8, 12, and 16 % micropatterned GelMA 2D
surface. The adhesion and spreading of HUVECs on 2D
GelMA surface at different time points are shown in Fig. 4a
while the area of confluency as quantified using the image
analysis software ImageJ is presented in Fig. 4b. The spreading
of HUVECs in the GelMA channel over time is shown in
Fig. 4c while Fig. 4d shows the actin-DAPI staining of a
HUVEC monolayer inside the lumen of a vessel. The high
concentration GelMA showed consistently higher adhesion
and spreading of cells. For 16 % GelMA, by day 3 after
seeding, an area of confluency of over 60 % was achieved
while those for 4, 8, and 12 % GelMAwere about 20, 30 and
45 % respectively, Figs. 4a and b. This trend is consistent with
earlier reports (Nichol et al. 2010) where the area of confluency
for 5 and 10 % GelMA with a cell seeding density of 2×106
cells/ml were about 10 and 18 % respectively, i.e., the higher
concentration of GelMA exhibited higher cell adhesion and
spreading. The values for the area of confluency was consis-
tently higher in the current study compared to earlier reported
studies on GelMA, for example Nichol and coworkers (Nichol
et al. 2010). This is because, the cell density used in this study
was 5 million/ml as opposed to 2 million/ml in earlier ones
(Nichol et al. 2010). It is also evident that higher GelMA con-
centrations help in faster spreading of surface seeded HUVECs,
Fig. 4a. However, lower concentration of GelMA results in
better viability for cells encapsulated in 3D, Fig. 3b and c.
Hence, based on these findings for optimum combination of
the two, we chose the 8 and 12 % GelMA concentrations for
subsequent fabrications. The formation of a confluent mono-
layer of HUVECs, in the luminal surface of the fabricated ves-
sel, is evident by day 3 from Fig. 4c, which is also confirmed by
the staining of cytoskeletal Actin fibers using Alexa fluor 488
(green) and DAPI staining (blue) of cell nucleus as shown in
Fig. 3 Viability of 3T3 fibroblast cells in the walls of the fabricated
vascular structure of cell encapsulated GelMA at different
concentrations over time. The cell-laden GelMA constructs were
stained with Calcein-AM (green) and ethidium homodimer (red) at
12 h, 2 and 3 days after encapsulation, a a vascular construct showing
the cells encapsulation in the vascular structure of GelMA, b live-dead
staining of 4, 8, 12 and 16%GelMA constructs after 12 h, 2 and 3 days, c
cell viability at different time points in 4, 8, 12 and 16 % GelMA
constructs after 12 h, 2 and 3 days. Cell viability in the low
concentration GelMA constructs were considerably higher compared to
high density GelMA. Scale bars=100 μm
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Fig. 4d. It is worth noting that even though the confluency of
HUVECs on 2D surface seeded on 16 % GelMA on day 3 was
about 60 %, as shown in Fig. 4a and b, the confluency on the
luminal surface of the tube on day 3 was over 90%. The higher
confluency in the lumen of the tube can be attributed to the
effect of shear flow in the lumen and the higher cell density
i.e., 20 million/ml as opposed to 5 million/ml on 2D surface.
3.6 Mechanical properties
The successful application of tissue engineering requires that
the mechanical properties of the engineered tissues be suitable
for the specific in vivo application (Hasan et al. 2014c). We,
therefore, investigated the uniaxial compressive mechanical
properties of the fabricated vessels for GelMA concentrations
of 4, 8, 12 and 16 % as described in section 2.9. The compres-
sive stress–strain curves for up to 50 % strain are shown in
supplementary Figure, Fig. S2 (a) while the compressive mod-
ulus, failure stress and failure strain at different concentrations
of GelMA are shown in Figs. S2 (b), (c) and (d) respectively.
The higher concentration GelMA samples showed higher stiff-
ness (modulus) and failure stress while the failure strains con-
sistently decreased with increasing concentration. An increase
of GelMA concentration from 4 to 16 % increased the com-
pressive modulus by almost 44 times, to 138 kPa from 3.1 kPa,
while the failure stress increased to 175 kPa from 43 kPa and
Fig. 4 Formation of the EC monolayer on 2DGelMA surface and inside
the lumen of the vascular-like structure, a GFP-fluorescent images
showing attachment, spreading and growth of HUVECs on 2D GelMA
surface at 4, 8, 12 and 16 % GelMA concentrations after 12 h, 1, 2 and
3 days of cell seeding, b area of confluence of HUVECs on 2D GelMA
surface over time for different GelMA concentrations. c Spreading of
HUVECs inside the lumen of a vascular-like structure with 12 %
GelMA concentration over time, and d a representative Phalloidin-
DAPI staining image showing the continuous monolayer of HUVECs
in the channel at 12 % GelMA concentration after 3 days of cell
seeding. The cells spread well on both the 2D surface and the luminal
surface, forming a cell monolayer, as is seen from the actin skeleton
(green) and the nucleus of the cells (blue). Scale bars in figures a are
100 μm while those in figures b and c are 200 μm
Fig. 5 Permeability of fluorescently labeled 10 kDA dextran to the walls of
the vessel-like structures from the flow in the lumen: a a vessel without any
EC layer at time zero of starting the dextran perfusion, b a vessel with an EC
monolayer at time zero of starting perfusion, c a vessel without any EC layer
after 20 min of dextran perfusion, d a vessel with an EC monolayer after
20 min of dextran perfusion. e and f Change in relative intensity of
fluorescence with respect to the distance from the center of the vessels for
the vascular-like structures without and with the ECmonolayer respectively.
The fluorescent intensity from line scannings across the vessels orthogonal
to the axial direction at their center in a and bwasmeasured at a time interval
of 10 min. The intensities were then normalized against the maximum
intensity values at the center of the vessel. g and h The relative intensity
values at a distance 300 μm from the center of the vessels at different time
points. The barrier function was obtained from the slope of the relative
intensity versus time graphs in g and h. Scale bars=200 μm
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the failure strain decreased to 58% from 85%. These values are
quite low compared to those of native vascular structures which
are usually in the MPa ranges. Therefore, the hydrogel-based
structures presented here are not mechanically strong enough
for use as implantable replacement blood vessels during vascu-
lar surgeries, however, they can be highly useful in in vitro
Time = 0 minute 
Time = 20 minute 
(e) (f) 
(c) (d) 
(a) (b) 
(g) (h) 
A bilayer vessel without EC 
layer
A trilayer vessel with EC 
continuous monolayer
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study of vascular mechanobiology and development of blood
vessels on chip models for drug screening and development of
in vitro models for cardiovascular diseases.
3.7 Barrier functions and permeability of the vascular
constructs
One of the requirements for functional vascular constructs is a
strong barrier function offered by the EC monolayer on the
luminal surface. In order to evaluate the barrier function, per-
meability of Alexa-Fluor-488 labeled dextran (Mw~10 kDA)
through the tri-layered vascular constructs was compared with
that of a bilayer vascular construct without any ECmonolayer.
The fluorescently labeled dextran was perfused through the
constructs, and the fluorescence intensity of the diffused dex-
tran in the walls of the constructs was measured at 10 min
intervals for 60 min. The intensity distributions were obtained
by line-scanning the fluorescent images near the center of the
tubes using the plot profile function in ImageJ software. The
relative intensity was obtained by normalizing against the in-
tensity at the center of the channel, which was also the max-
imum intensity value along the respective curves. Fig. 5a and
b show the fluorescence image of two vascular constructs, one
without any HUVECs monolayer, and the other with a
HUVECs monolayer at time zero of perfusing the fluorescent
dextran through the lumen. Fig. 5c and d show those images
after 20 min of continuous perfusion. The relative intensity
distribution from the center of the channel to the walls of
vessels are shown in Fig. 5e and f while the relative intensity
values at a distance 300 μm from the center of the channel,
i.e., 200 μm from the luminal surface at different time points
are plotted in Figs. 5g and h respectively. These figures show a
high rate of diffusion of dextran in the vascular construct
without EC monolayer compared to the tri-layered vascular
construct with a HUVEC monolayer. While the relative inten-
sity in the construct without the EC monolayer continuously
increased with time, the tri-layered vascular-like construct
showed very small increase in the relative intensity with time,
indicating a strong barrier effect by the EC monolayer. The
diffusion properties in the constructs were compared using the
slopes of the best fitting curves. The slopes for the bilayer
vascular-like structure without any EC layer and the tri-
layered construct with a continuous EC monolayer were
2.87×10−3 min−1 and 4.88×10−4 min−1 respectively, indicat-
ing an order of magnitude decrease in the diffusion properties
due to the presence of EC monolayer in the construct.
4 Conclusions
Perfusable tri-layered blood vessel-like structures on a
microfluidic platform has been developed. The method used
in this study allows fabrication of a range of vascular-like
structures, with varying wall thicknesses as well as different
thicknesses of the different wall layers, and different lumen
diameters. The vascular-like structures developed using our
technique were grown for several days with the continuous
perfusion of media through the lumen of the vessels. The cells
remained viable under this condition. The mechanical proper-
ties of the vascular constructs changed significantly depend-
ing on the concentration of GelMA. The developed vessels
with a continuous EC monolayer demonstrated strong barrier
functions compared to bare tubes without any EC monolayer.
The multilayer vessel will have multifaceted applications in-
cluding development of in vitro models of various cardiovas-
cular diseases such as atherosclerosis and hypertension, study
of cancer metastasis, on chip human-tissue-model for screen-
ing of potential drug candidates. In the future in vitro investi-
gations of cell mechanobiology such as effects of flow and
mechanical stresses on ECs to SMCs interactions and signal-
ing cascades will also be assessed.
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